FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) has been notified of an unsolicited “mini-tender” offer by TRC Capital Corporation to purchase up to 3 million shares, or approximately 0.37%, of the outstanding Gilead common stock at a price of $37.25 per share. TRC’s offer price represents approximately a 4.56% discount to the $39.03 closing price of Gilead common stock on March 2, 2011, the last closing price prior to commencement of the offer. In addition, TRC’s offer is subject to numerous conditions, including the availability of financing under a credit facility satisfactory to TRC.
